03
August
2022


Share on networks

The German company Merck has invested 14.5 million euros in its facilities in Mollet del Vallès (Barcelona). This large investment will meet increased demand for the company’s specific products in its Life Sciences sector, such as the production of some Covid-19 vaccines.

The expansion project is a further demonstration of the Merck Group’s commitment to its operations in Catalonia while reinforcing its commitment to international supply solutions at this site, as production from the new building will be exported around the world.

Miguel Fernández Alcalde, Managing Director of Merck in Spain, said: “In the last 4 years Merck has invested a total of 90 million euros in the Mollet del Vallès site and in the biotechnology plant in Tres Cantos (Madrid). This has had a clear impact on our production and export capacity from Spain. Specifically, around 99% of the production developed at the Mollet del Vallès site is exported to other countries”.

Share on networks

Related news

-	Catalunya bat el rècord d’empreses estrangeres instal·lades, amb més de 9.600

News

Record number of foreign companies established in Catalonia: over 9,600

News

Real estate investment in Barcelona recovers, hitting €1.5 billion for year through September

L’economia catalana creix un 0,9% el tercer trimestre i el PIB interanual s’incrementa un 3,8%

News

Catalan economy grows 0.9% in third quarter and year-on-year GDP is up 3.8%